1. A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells
   Bei Zhao et al, 2020, Frontiers in Pharmacology CrossRef
2. Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
   Jun Lu et al, 2019, Frontiers in Oncology CrossRef
3. Evaluation of the Effectiveness of Herbal Components Based on Their Regulatory Signature on Carcinogenic Cancer Cells
   Fazileh Esmaeili et al, 2021, Cells CrossRef
4. Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
   Xiaoming Huang et al, 2021, Current Pharmaceutical Biotechnology CrossRef
5. Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
   Jun Lu et al, 2019, BMC Medical Genomics CrossRef
6. Integrative RNA-Seq and ATAC-Seq Analysis Reveals the Migration-Associated Genes Involved in Antitumor Effects of Herbal Medicine Feiyanning on Lung Cancer Cells
   Chenyang Wang et al, 2021, Frontiers in Genetics CrossRef